- ILUMYA has been approved by MHLW for use in Japan.
- ILUMYA can treat plaque psoriasis in adult patients.
A fully owned subsidiary of Sun Pharmaceutical Industries has been approved by Ministry of Health, Labour and Welfare (MHLW), Japan. ILUMYA (tildrakizumab) is useful for the treatment of plaque psoriasis in adult patients who could not be benefitted with conventional ....
Tags : Japan Ministry of Health, Labour and Welfare, MHLW, chemokines, cytokines, Sun Pharma, Major Adverse Cardiovascular Event, MACE,